Engineering tolerance using biomaterials to target and control antigen presenting cells

Discovery Medicine

Volumn 21, Issue 117, 2016, Pages 403-410

  Tostanoski, Lisa H ^a   Gosselin, Emily A ^a   Jewell, Christopher M ^a,b,c  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; DRUG CARRIER; IMMUNOSUPPRESSIVE AGENT; NANOPARTICLE; TOLL LIKE RECEPTOR AGONIST; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; AUTOANTIGEN; CYTOKINE; IMMUNOLOGIC FACTOR;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; CELL MIGRATION; CELL PROLIFERATION; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; PARTICLE SIZE; REGULATORY T LYMPHOCYTE; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; BIOENGINEERING; CELL DIFFERENTIATION; CHEMISTRY; DIABETES MELLITUS, TYPE 1; DRUG DELIVERY SYSTEM; DRUG EFFECTS; IMMUNOLOGY; IMMUNOTHERAPY; LUPUS ERYTHEMATOSUS, SYSTEMIC; METABOLISM; PROCEDURES; TRENDS;

ANIMALS; AUTOANTIGENS; BIOCOMPATIBLE MATERIALS; BIOENGINEERING; CELL DIFFERENTIATION; CYTOKINES; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; DRUG DELIVERY SYSTEMS; HUMANS; IMMUNE TOLERANCE; IMMUNOLOGIC FACTORS; IMMUNOTHERAPY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MULTIPLE SCLEROSIS; PARTICLE SIZE;

EID: 85007298385     PISSN: 15396509     EISSN: 19447930     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Andorko JI, Hess KL, Jewell CM. Harnessing biomaterials to engineer the lymph node microenvironment for immunity or tolerance. AAPS J 17(2):323-338, 2015a.
2. Andorko JI, Hess KL, Pineault KG, Jewell CM. Intrinsic immunogenicity of rapidly-degradable polymers evolves during degradation. Acta Biomater, 2015b.
3. Aspelund A, Antila S, Proulx ST, Karlsen TV, Karaman S, Detmar M, Wiig H, Alitalo K. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med 212(7):991-999, 2015.
4. Bluestone JA, Bour-Jordan H, Cheng M, Anderson M. T cells in the control of organ-specific autoimmunity. J Clin Invest 125(6):2250-2260, 2015.
5. Bryant J, Hlavaty KA, Zhang X, Yap WT, Zhang L, Shea LD, Luo XR. Nanoparticle delivery of donor antigens for transplant tolerance in allogeneic islet transplantation. Biomaterials 35(31):8887-8894, 2014.
6. Buck MD, O'sullivan D, Pearce EL. T cell metabolism drives immunity. J Exp Med 212(9):1345-1360, 2015.
7. Chalmers SA, Chitu V, Ramanujam M, Putterman C. Therapeutic targeting of macrophages in lupus nephritis. Discov Med 108:43-49, 2015.
8. Chiu YC, Gammon JM, Andorko JI, Tostanoski LH, Jewell CM. Modular vaccine design using carrier-free capsules assembled from polyionic immune signals. ACS Biomater Sci Eng 1(12):1200-1205, 2015.
9. Dane KY, Nembrini C, Tomei AA, Eby JK, O'neil CP, Velluto D, Swartz MA, Inverardi L, Hubbell JA. Nano-sized drug-loaded micelles deliver payload to lymph node immune cells and prolong allograft survival. J Control Release 156(2):154-160, 2011.
10. Foged C, Brodin B, Frokjaer S, Sundblad A. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm 298(2):315-322, 2005.
11. Gammon JM, Tostanoski LH, Adapa AR, Chiu YC, Jewell CM. Controlled delivery of a metabolic modulator promotes regulatory T cells and restrains autoimmunity. J Control Release 210:169-178, 2015.
12. Getts DR, Martin AJ, Mccarthy DP, Terry RL, Hunter ZN, Yap WT, Getts MT, Pleiss M, Luo X, King NJ, Shea LD, Miller SD. Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis. Nature Biotechnol 30(12):1217-1224, 2012.
13. Getts DR, Terry RL, Getts MT, Deffrasnes C, Muller M, Van Vreden C, Ashhurst TM, Chami B, Mccarthy D, Wu HL, Ma J, Martin A, Shae LD, Witting P, Kansas GS, Kuhn J, Hafezi W, Campbell IL, Reilly D, Say J, et al. Therapeutic inflammatory monocyte modulation using immune-modifying microparticles. Sci Transl Med 6(219), 2014.
14. Griffith TS, Ferguson TA. Cell death in the maintenance and abrogation of tolerance: the five Ws of dying cells. Immunity 35(4):456-466, 2011.
15. Grimm AJ, Kontos S, Diaceri G, Quaglia-Thermes X, Hubbell JA. Memory of tolerance and induction of regulatory T cells by erythrocyte-targeted antigens. Sci Rep 5:15907, 2015.
16. Hlavaty KA, Luo X, Shea LD, Miller SD. Cellular and molecular targeting for nanotherapeutics in transplantation tolerance. Clin Immunol 160(1):14-23, 2015.
17. Hudalla GA, Sun T, Gasiorowski JZ, Han HF, Tian YF, Chong AS, Collier JH. Gradated assembly of multiple proteins into supramolecular nanomaterials. Nat Mater 13(8):829-836, 2014.
18. Hunter Z, Mccarthy DP, Yap WT, Harp CT, Getts DR, Shea LD, Miller SD. A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease. ACS Nano 8(3):2148-2160, 2014.
19. Irvine DJ, Swartz MA, Szeto GL. Engineering synthetic vaccines using cues from natural immunity. Nat Mater 12(11):978-990, 2013.
20. Jewell CM, Lopez SCB, Irvine DJ. In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles. Proc Natl Acad Sci U S A 108(38):15745-15750, 2011.
21. Jhunjhunwala S, Raimondi G, Thomson AW, Little SR. Delivery of rapamycin to dendritic cells using degradable microparticles. J Control Release 133(3):191-197, 2009.
22. Jones CH, Hill A, Chen MF, Pfeifer BA. Contemporary approaches for nonviral gene therapy. Discov Med 107:447-454, 2015.
23. Kontos S, Kourtis IC, Dane KY, Hubbell JA. Engineering antigens for in situ erythrocyte binding induces T-cell deletion. Proc Natl Acad Sci U S A 110(1):E60-E68, 2013.
24. Kwon YJ, James E, Shastri N, Frechet JMJ. In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles. Proc Natl Acad Sci U S A 102(51):18264-18268, 2005.
25. Lewis JS, Dolgova NV, Zhang Y, Xia CQ, Wasserfall CH, Atkinson MA, Clare-Salzler MJ, Keselowsky BG. A combination dual-sized microparticle system modulates dendritic cells and prevents type 1 diabetes in prediabetic NOD mice. Clin Immunol 160(1):90-102, 2015.
26. Lewis JS, Zaveri TD, Crooks CP, Keselowsky BG. Microparticle surface modifications targeting dendritic cells for non-activating applications. Biomaterials 33(29):7221-7232, 2012.
27. Liu HP, Moynihan KD, Zheng YR, Szeto GL, Li AV, Huang B, Van Egeren DS, Park C, Irvine DJ. Structure-based programming of lymph-node targeting in molecular vaccines. Nature 507(7493):519-522, 2014.
28. Look M, Stern E, Wang QA, Diplacido LD, Kashgarian M, Craft J, Fahmy TM. Nanogel-based delivery of mycophenolic acid ameliorates systemic lupus erythematosus in mice. J Clin Invest 123(4):1741-1749, 2013.
29. Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, Derecki NC, Castle D, Mandell JW, Lee KS, Harris TH, Kipnis J. Structural and functional features of central nervous system lymphatic vessels. Nature 523(7560):337-341, 2015.
30. Lutterotti A, Martin R. Antigen-specific tolerization approaches in multiple sclerosis. Expert Opin Investig Drugs 23(1):9-20, 2014.
31. Maldonado RA, Lamothe RA, Ferrari JD, Zhang A-H, Rossi RJ, Kolte PN, Griset AP, O'neil C, Altreuter DH, Browning E, Johnston L, Farokhzad OC, Langer R, Scott DW, Von Andrian UH, Kishimoto TK. Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance. Proc Natl Acad Sci U S A 112(2):E156-E165, 2015.
32. Maldonado RA, Von Andrian UH. How tolerogenic dendritic cells induce regulatory T cells. Adv Immunol 108:111-165, 2010.
33. Manicassamy S, Pulendran B. Dendritic cell control of tolerogenic responses. Immunol Rev 241:206-227, 2011.
34. Mankia K, Emery P. Is localized autoimmunity the trigger for rheumatoid arthritis? Unravelling new targets for prevention. Discov Med 109:129-135, 2015.
35. Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 7(8):610-621, 2007.
36. Mueller SN, Germain RN. Stromal cell contributions to the homeostasis and functionality of the immune system. Nat Rev Immunol 9(9):618-629, 2009.
37. Northrup L, Christopher MA, Sullivan BP, Berkland C. Combining antigen and immunomodulators: Emerging trends in antigen-specific immunotherapy for autoimmunity. Adv Drug Deliv Rev 98:86-98, 2015.
38. Northrup L, Sestak JO, Sullivan BP, Thati S, Hartwell BL, Siahaan TJ, Vines CM, Berkland C. Co-delivery of autoantigen and b7 pathway modulators suppresses experimental autoimmune encephalomyelitis. AAPS J 16(6):1204-1213, 2014.
39. Osorio F, Fuentes C, Lopez MN, Salazar-Onfray F, Gonzalez FE. Role of dendritic cells in the induction of lymphocyte tolerance. Front Immunol 6:535, 2015.
40. Peine KJ, Guerau-De-Arellano M, Lee P, Kanthamneni N, Severin M, Probst GD, Peng H, Yang Y, Vangundy Z, Papenfuss TL, Lovett-Racke AE, Bachelder EM, Ainslie KM. Treatment of experimental autoimmune encephalomyelitis by codelivery of disease associated Peptide and dexamethasone in acetalated dextran microparticles. Mol Pharm 11(3):828-835, 2014.
41. Pereira BD, Fraefel C. Novel immunotherapeutic approaches in targeting dendritic cells with virus vectors. Discov Med 109:111-119, 2015.
42. Reddy ST, Van Der Vlies AJ, Simeoni E, Angeli V, Randolph GJ, O'neil CP, Lee LK, Swartz MA, Hubbell JA. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nature Biotechnol 25(10):1159-1164, 2007.
43. Salmond RJ, Zamoyska R. The influence of mTOR on T helper cell differentiation and dendritic cell function. Eur J Immunol 41(8):2137-2141, 2011.
44. Shao K, Singha S, Clemente-Casares X, Tsai S, Yang Y, Santamaria P. Nanoparticle-based immunotherapy for cancer. ACS Nano 9(1):16-30, 2015.
45. Sharp FA, Ruane D, Claass B, Creagh E, Harris J, Malyala P, Singh M, O'hagan DT, Petrilli V, Tschopp J, O'neill LaJ, Lavelle EC. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc Natl Acad Sci U S A 106(3):870-875, 2009.
46. Shirali AC, Look M, Du W, Kassis E, Stout-Delgado HW, Fahmy TM, Goldstein DR. Nanoparticle delivery of mycophenolic acid upregulates PD-L1 on dendritic cells to prolong murine allograft survival. Am J Tranplant 11(12):2582-2592, 2011.
47. Singh A, Peppas NA. Hydrogels and scaffolds for immunomodulation. Adv Mater 26(38):6530-6541, 2014.
48. Soroosh P, Doherty TA, Duan W, Mehta AK, Choi H, Adams YF, Mikulski Z, Khorram N, Rosenthal P, Broide DH, Croft M. Lung-resident tissue macrophages generate Foxp3+ regulatory T cells and promote airway tolerance. J Exp Med 210(4):775-788, 2013.
49. Sunshine JC, Green JJ. Nanoengineering approaches to the design of artificial antigen-presenting cells. Nanomedicine (Lond) 8(7):1173-1189, 2013.
50. Sunshine JC, Perica K, Schneck JP, Green JJ. Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells. Biomaterials 35(1):269-277, 2014.
51. Taner T, Hackstein H, Wang Z, Morelli AE, Thomson AW. Rapamycin-treated, alloantigen-pulsed host dendritic cells induce ag-specific T cell regulation and prolong graft survival. Am J Transplant 5(2):228-236, 2005.
52. Thomson AW, Turnquist HR, Raimondi G. Immunoregulatory functions of mTOR inhibition. Nat Rev Immunol 9(5):324-337, 2009.
53. Tsai S, Shameli A, Yamanouchi J, Clemente-Casares X, Wang J, Serra P, Yang Y, Medarova Z, Moore A, Santamaria P. Reversal of autoimmunity by boosting memory-like autoregulatory T cells. Immunity 32(4):568-580, 2010.
54. Van Broekhoven CL, Parish CR, Demangel C, Britton WJ, Altin JG. Targeting dendritic cells with antigen-containing liposomes: A highly effective procedure for induction of antitumor immunity and for tumor immunotherapy. Cancer Res 64(12):4357-4365, 2004.
55. Wang C, Yosef N, Gaublomme J, Wu C, Lee Y, Clish CB, Kaminski J, Xiao S, Meyer Zu Horste G, Pawlak M, Kishi Y, Joller N, Karwacz K, Zhu C, Ordovas-Montanes M, Madi A, Wortman I, Miyazaki T, Sobel RA, Park H, et al. CD5L/AIM regulates lipid biosynthesis and restrains Th17 cell pathogenicity. Cell 163(6):1413-1427, 2015.
56. Zhang PP, Chiu YC, Tostanoski LH, Jewell CM. Polyelectrolyte multilayers assembled entirely from immune signals on gold nanoparticle templates promote antigen-specific T cell response. ACS Nano 9(6):6465-6477, 2015.